• home
  • leadership
  • innovation
  • billionaires
  • startups
  • AI Tracker
  • Lists
    India Rich List 2025AI Special 2025W Power 202530 Under 30 2025India Rich List 2024Digital Stars 2024All Lists
  • Podcasts
    To The PointTech ConversationsMoney TalksStartup FridaysFrom the BookshelvesAll Podcasts
  • Videos
    Leadership MantrasPathbreakersLets Talk AboutOne Thing Today in TechMomentumNuts and BoltsIn Conversation WithFrom the FieldBeyond the BoardroomAll Videos
  • Magazine
  • More
    NewsLifeThought LeadershipBlogs

ranbaxy

Advertisement
Forbes List Logo
India's 'pharmacy of the world' moniker is under threat. Here's why
Despite regulatory issues and pricing pressures, can India continue being the world's generic capital?
ByNaini Thaker
No incentive for quality in generic drugs world: Katherine Eban
ByPooja Sarkar
India's Richest 2019: A giant leap for Mankind
ByRajiv Singh
Mergers and Acquisitions: Outlook in India for 2018
ByAshish Parwani, Rajeev Nair and Gitika Makhija
Under Whose Watch Did The Ranbaxy Fraud Happen?
ByRohin Dharmakumar
Advertisement
It's not just Ranbaxy, our health care regulators have failed us too
BySeema Singh
Why whistle blowing is so hard in India
ByNitin Paranjpe

Explore More Tags

gst (12)donald-trump (8)apple (4)fashion (4)healthcare (4)india (4)automobile (3)bharat-forge (3)economy (3)gig-economy (3)
  • Home
  • /
  • Ranbaxy
Subscribe Now
Advertisement
Advertisement
Advertisement

Latest News

  • Photo of the day: Mumbai gets a new luxury destination
    ByForbes India
  • Book review: Secession of the successful by Sanjaya Baru
    ByIIM Bangalore
  • The curious quirk of the base effect in inflation
    BySamreen Wani
  • Graphic of the day: Tax Growth Slows
    BySamreen Wani